While Januvia’s label bears a warning about the drug’s tendency to increase a patient’s risk of pancreatitis, a painful inflammation of the pancreas, Januvia’s link to pancreatic cancer, which kills most of its victims within a year, is less settled. But a recent study by the chairman of endocrinology at the University of California, Los Angeles, may change that…. Read more
Januvia Lawsuit Center
Research shows the antidiabetic drug sitagliptin phosphate—sold under the brand name Januvia (and as Janumet when combined with metformin)—causes acute pancreatitis and pancreatic cancer.
In March 2013, the FDA announced that it is evaluating findings that connects Januvia with pancreatitis and cellular changes called “pancreatic duct metaplasia.”
If you’ve suffered harm resulting from taking Januvia, then you might have a case against Merck & Co., the manufacturer of the drug.
You’ll need to make a claim, though, and your time to do so is limited. Call us now and speak to one of our lawyers, at no cost or risk. We can determine promptly whether you have grounds for a lawsuit.
If you were prescribed Januvia, then developed cancer, you might be entitled to compensation for your injuries, including out-of-pocket costs, lost wages, and pain and suffering.
Don’t expect the drug’s maker to volunteer to write you a check, though. You’ll need to demand to be made whole.
Januvia (sitagliptin) is a medication prescribed to patients suffering from type 2 diabetes in order to regulate blood sugar. Combined with a healthy diet and exercise, Januvia is supposed to control the condition, helping avoid other illnesses associated with type 2 diabetes, including heart attack and stroke.
Diabetes is a condition that affects more than 23 million Americans, with many grappling with type 2 diabetes, which can be brought on by poor diet and lack of exercise. Medications like Januvia (sitagliptin) have become popular treatments for type 2 diabetes, but carry with them certain side effects.
The number of patients that have experienced adverse reactions to the type 2 diabetes drug Januvia is growing, as is the number of lawsuits against Merck & Co., the drug’s manufacturer. Januvia has been linked to pancreatitis, as well as to an increased the risk of pancreatic and thyroid cancers.